Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | 102,225 | reported | 03 Jun 2024 | tx 5+225,877−12,099 |
| ARS Pharmaceuticals, Inc. | 30,000 | reported | 25 Jun 2025 | tx 86+2,152,694−1,922,550 |
| Nkarta, Inc. | 16,000 | reported | 08 Jun 2022 | tx 4+61,511 |
| Synthorx, Inc. | 0 | reported | 23 Jan 2020 | tx 19+955,453−1,791,390 |
| CRITICAL THERAPEUTICS INC | 0 | reported | 03 Feb 2014 | tx 4+35,000−35,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jun 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 07 Apr 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 22,509 | 4.85 USD | |
| 07 Apr 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 27,493 | 4.85 USD | |
| 07 Apr 2025 | SALE | ARS Pharmaceuticals, Inc. | 50,002 | 12.30 USD | |
| 07 Apr 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 22,509 | 0.00 USD | deriv |
| 07 Apr 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 27,493 | 0.00 USD | deriv |
| 05 Mar 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 400 | 4.85 USD | |
| 06 Mar 2025 | SALE | ARS Pharmaceuticals, Inc. | 49,600 | 11.21 USD | |
| 06 Mar 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 49,600 | 4.85 USD | |
| 05 Mar 2025 | SALE | ARS Pharmaceuticals, Inc. | 400 | 11.00 USD | anomaly |
| 06 Mar 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 49,600 | 0.00 USD | deriv |
| 05 Mar 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 400 | 0.00 USD | deriv |
| 03 Feb 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 40,936 | 4.85 USD | |
| 03 Feb 2025 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 12.31 USD | |
| 03 Feb 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 9,064 | 3.15 USD | |
| 03 Feb 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 40,936 | 0.00 USD | deriv |
| 03 Feb 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 9,064 | 0.00 USD | deriv |
| 06 Jan 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 50,000 | 3.15 USD | |
| 06 Jan 2025 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 11.10 USD | |
| 06 Jan 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 03 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 25,606 | 1.27 USD | |
| 02 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 67,616 | 1.27 USD | |
| 04 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 14,772 | 13.75 USD | |
| 04 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 14,772 | 3.15 USD | |
| 02 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 96,343 | 13.55 USD |